SC 13D/A

ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#2)

Company: Vir Biotechnology, Inc.
Filed: April 14, 2021
Accession Number: 0001072613-21-000371

View Document ↗ View on SEC.gov ↗